…
comment: The repository administrator has not yet configured an RDF license.
primary topic: SGLT2 INHIBITORS BEYOND DIABETES A RETROSPECTIVE AUDIT OF PRESCRIBING PATTERNS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

SGLT2 INHIBITORS BEYOND DIABETES A RETROSPECTIVE AUDIT OF PRESCRIBING PATTERNS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
type: AcademicArticle
type: Article
abstract: Heart failure with preserved ejection fraction (HFpEF) constitutes a substantial and increasing proportion of heart failure cases worldwide, with historically limited evidence-based therapeutic options. Sodium–glucose co-transporter 2 (SGLT2) inhibitors, initially developed for the management of type 2 diabetes mellitus, have demonstrated significant cardiovascular benefits, including reductions in heart failure hospitalizations and improvement in functional outcomes, irrespective of glycemic status. This retrospective audit aimed to evaluate prescribing patterns of SGLT2 inhibitors in patients with HFpEF, with particular emphasis on their utilization beyond diabetes.
date: 2026-05-10
status: published
author list: authors
type: EPrint
type: ArticleEPrint
is part of: repository

Research Science and Innovation House
type: Organization

SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES
type: Collection

Saifullah
type: Person
family name: Saifullah

Haleema Iqbal
type: Person
family name: Haleema Iqbal

Nayab Nisar
type: Person
given name: Nayab
family name: Nisar

Mehak Nazeem
type: Person
given name: Mehak
family name: Nazeem

HTML Summary of #87757 SGLT2 INHIBITORS BEYOND DIABETES A RETROSPECTIVE AUDIT OF PRESCRIBING PATTERNS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
format: text/html
primary topic: SGLT2 INHIBITORS BEYOND DIABETES A RETROSPECTIVE AUDIT OF PRESCRIBING PATTERNS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION